Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A framework for considering the risk‐benefit trade‐off in designing noninferiority trials using composite outcome approaches

Statistics in Medicine(2020)10.1002/sim.8777Source: DataRank Database

A framework for considering the risk‐benefit trade‐off in designing noninferiority trials using composite outcome approaches is a research paper published in Statistics in Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.21)OA: greenTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Ritesh Ramchandani ORCID,Sachiko Miyahara ORCID,Soyeon Kim ORCID,Grace Montepiedra ORCID

Live enrichment

PubMed:33105524 PMC:PMC7770022 OpenAlex:https://openalex.org/W3094146405

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068616‐12

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068634

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068636

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI106701

NIAID NIH HHS

Grant: U01 AI068634

NIAID NIH HHS

Grant: UM1 AI106716

NIAID NIH HHS

Grant: UM1 AI068616

National Institutes of Health

Grant: 5UM1AI068616-14

SDMC - IMPAACT Leadership Group

National Institutes of Health

Grant: 3UM1AI106701-12S1

AIDS Clinical Trial Group Laboratory Center

National Institutes of Health

Grant: 3UM1AI068636-19SC

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

National Institutes of Health

FWCI

0.21

Citation Percentile

0.6%

Citation Trend

2022

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7770022

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8777

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/sim.8777

journalhttps://doi.org/10.1002/sim.8777

Fields of Study

Statistical Methods in Clinical TrialsHealth Systems, Economic Evaluations, Quality of LifeAdvanced Causal Inference Techniques01 natural sciences03 medical and health sciences0302 clinical medicine0101 mathematicsModels, StatisticalResearch DesignRisk AssessmentTreatment Outcome

MeSH Terms

Research DesignModels, StatisticalTreatment OutcomeRisk Assessment

Keywords

TolerabilityOutcome (game theory)RegimenMargin (machine learning)Clinical trialMedicineStatisticsComputer scienceMathematicsAdverse effectInternal medicineMachine learningTuberculosisTrial DesignNoninferiority MarginRisk-benefitComposite OutcomeModels, StatisticalRisk AssessmentApplications of statistics to biology and medical sciences; meta analysisTreatment OutcomeResearch Design

Sustainable Development Goals

SDG 0: Partnerships for the goals